 Mark Sawyer
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 4 | 2024 | 38 | 2.090 |
Why?
| | Appendicitis | 2 | 2024 | 130 | 1.570 |
Why?
| | Nephrolithotomy, Percutaneous | 1 | 2024 | 4 | 0.870 |
Why?
| | Nephrostomy, Percutaneous | 1 | 2024 | 9 | 0.870 |
Why?
| | Radiation Exposure | 1 | 2024 | 49 | 0.820 |
Why?
| | Urography | 1 | 2023 | 17 | 0.810 |
Why?
| | Prostate | 1 | 2024 | 175 | 0.780 |
Why?
| | Drug Hypersensitivity | 1 | 2023 | 90 | 0.730 |
Why?
| | Surgery, Computer-Assisted | 1 | 2023 | 101 | 0.730 |
Why?
| | Anaphylaxis | 1 | 2023 | 105 | 0.730 |
Why?
| | Quality Improvement | 3 | 2024 | 1178 | 0.720 |
Why?
| | Carbon Dioxide | 1 | 2023 | 267 | 0.690 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 307 | 0.680 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 255 | 0.660 |
Why?
| | Anti-Bacterial Agents | 4 | 2024 | 1809 | 0.660 |
Why?
| | Contrast Media | 1 | 2023 | 467 | 0.640 |
Why?
| | Endoscopy | 4 | 2023 | 318 | 0.570 |
Why?
| | Nephrolithiasis | 2 | 2013 | 11 | 0.520 |
Why?
| | Urine | 2 | 2013 | 59 | 0.500 |
Why?
| | Prostatic Neoplasms | 1 | 2024 | 1043 | 0.500 |
Why?
| | Urologic Surgical Procedures | 3 | 2010 | 120 | 0.450 |
Why?
| | Appendectomy | 2 | 2024 | 79 | 0.430 |
Why?
| | Calcium | 3 | 2013 | 1199 | 0.390 |
Why?
| | Antibiotic Prophylaxis | 2 | 2023 | 119 | 0.350 |
Why?
| | Creatinine | 1 | 2012 | 499 | 0.340 |
Why?
| | Cystoscopy | 1 | 2009 | 21 | 0.320 |
Why?
| | Urologists | 2 | 2019 | 17 | 0.320 |
Why?
| | Cystectomy | 1 | 2009 | 37 | 0.310 |
Why?
| | Body Weight | 1 | 2013 | 985 | 0.300 |
Why?
| | Urinary Catheterization | 1 | 2008 | 33 | 0.280 |
Why?
| | Catheterization | 1 | 2008 | 179 | 0.270 |
Why?
| | Foreign Bodies | 1 | 2008 | 104 | 0.260 |
Why?
| | Models, Biological | 1 | 2013 | 1783 | 0.240 |
Why?
| | Urinary Bladder | 1 | 2008 | 183 | 0.240 |
Why?
| | Metronidazole | 1 | 2024 | 20 | 0.230 |
Why?
| | Ceftriaxone | 1 | 2024 | 21 | 0.230 |
Why?
| | Humans | 24 | 2024 | 137585 | 0.220 |
Why?
| | Urologic Diseases | 2 | 2017 | 41 | 0.220 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 39 | 0.220 |
Why?
| | Prone Position | 1 | 2024 | 30 | 0.210 |
Why?
| | Nephrectomy | 2 | 2019 | 169 | 0.210 |
Why?
| | Supine Position | 1 | 2024 | 39 | 0.210 |
Why?
| | Prostatectomy | 1 | 2024 | 104 | 0.210 |
Why?
| | Clindamycin | 1 | 2023 | 15 | 0.210 |
Why?
| | Patient Positioning | 1 | 2024 | 67 | 0.200 |
Why?
| | Cefazolin | 1 | 2023 | 21 | 0.200 |
Why?
| | Penicillins | 1 | 2023 | 58 | 0.200 |
Why?
| | Fluoroscopy | 1 | 2023 | 154 | 0.190 |
Why?
| | Rectum | 1 | 2024 | 185 | 0.190 |
Why?
| | Vancomycin | 1 | 2023 | 84 | 0.190 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2024 | 252 | 0.180 |
Why?
| | Fractures, Open | 1 | 2021 | 29 | 0.180 |
Why?
| | Acute Disease | 1 | 2024 | 1007 | 0.170 |
Why?
| | Laparoscopy | 3 | 2010 | 466 | 0.170 |
Why?
| | Fuzzy Logic | 1 | 2000 | 8 | 0.170 |
Why?
| | Pharmacists | 1 | 2023 | 265 | 0.170 |
Why?
| | Biopsy | 1 | 2024 | 1129 | 0.160 |
Why?
| | Imaging, Three-Dimensional | 1 | 2023 | 580 | 0.150 |
Why?
| | Treatment Outcome | 2 | 2024 | 10811 | 0.150 |
Why?
| | Low Back Pain | 1 | 2019 | 108 | 0.140 |
Why?
| | Occupational Diseases | 1 | 2019 | 156 | 0.140 |
Why?
| | Men's Health | 1 | 2017 | 7 | 0.140 |
Why?
| | Male | 10 | 2024 | 67762 | 0.130 |
Why?
| | Review Literature as Topic | 1 | 2017 | 75 | 0.130 |
Why?
| | Middle Aged | 8 | 2024 | 33479 | 0.120 |
Why?
| | Surgeons | 1 | 2019 | 297 | 0.120 |
Why?
| | Young Adult | 3 | 2024 | 13209 | 0.110 |
Why?
| | Adult | 6 | 2024 | 37929 | 0.100 |
Why?
| | Veterans | 1 | 2024 | 1476 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 1 | 2023 | 2691 | 0.100 |
Why?
| | Calcium Oxalate | 1 | 2012 | 5 | 0.100 |
Why?
| | Calcium Phosphates | 1 | 2012 | 27 | 0.100 |
Why?
| | Secondary Prevention | 1 | 2013 | 233 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3566 | 0.090 |
Why?
| | Organ Size | 1 | 2012 | 477 | 0.090 |
Why?
| | Kidney Pelvis | 1 | 2011 | 24 | 0.090 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.090 |
Why?
| | Female | 8 | 2024 | 73304 | 0.090 |
Why?
| | Terminology as Topic | 2 | 2010 | 216 | 0.090 |
Why?
| | Endoscopes | 1 | 2010 | 17 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 692 | 0.080 |
Why?
| | Urology | 1 | 2010 | 63 | 0.080 |
Why?
| | Ergonomics | 2 | 2019 | 26 | 0.080 |
Why?
| | Seasons | 1 | 2012 | 547 | 0.080 |
Why?
| | Urethra | 1 | 2009 | 55 | 0.080 |
Why?
| | Stomach | 1 | 2009 | 110 | 0.080 |
Why?
| | Precision Medicine | 1 | 2013 | 429 | 0.080 |
Why?
| | Ureter | 1 | 2008 | 36 | 0.070 |
Why?
| | Swine | 1 | 2009 | 775 | 0.070 |
Why?
| | Ileal Neoplasms | 1 | 2005 | 3 | 0.060 |
Why?
| | Ileal Diseases | 1 | 2005 | 13 | 0.060 |
Why?
| | Intestinal Perforation | 1 | 2005 | 46 | 0.060 |
Why?
| | Cohort Studies | 1 | 2012 | 5742 | 0.050 |
Why?
| | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2001 | 1 | 0.050 |
Why?
| | Mutagens | 1 | 2001 | 22 | 0.050 |
Why?
| | Genes, p53 | 1 | 2001 | 72 | 0.040 |
Why?
| | Hemochromatosis | 1 | 2000 | 11 | 0.040 |
Why?
| | Prospective Studies | 1 | 2013 | 7604 | 0.040 |
Why?
| | Hepatolenticular Degeneration | 1 | 2000 | 15 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2001 | 375 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2000 | 329 | 0.040 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 530 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2005 | 940 | 0.030 |
Why?
| | Global Burden of Disease | 1 | 2017 | 24 | 0.030 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 31 | 0.030 |
Why?
| | Infertility, Male | 1 | 2017 | 61 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2017 | 113 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1587 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2000 | 528 | 0.030 |
Why?
| | Global Health | 1 | 2019 | 386 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 431 | 0.030 |
Why?
| | Adolescent | 2 | 2013 | 21513 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1164 | 0.030 |
Why?
| | Lung Neoplasms | 2 | 2005 | 2526 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2021 | 15657 | 0.030 |
Why?
| | Mutation | 2 | 2001 | 3958 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2734 | 0.020 |
Why?
| | Humidity | 1 | 2012 | 50 | 0.020 |
Why?
| | Cognition | 1 | 2000 | 1153 | 0.020 |
Why?
| | Urinalysis | 1 | 2012 | 77 | 0.020 |
Why?
| | Liver | 1 | 2000 | 1943 | 0.020 |
Why?
| | Animals | 3 | 2009 | 36940 | 0.020 |
Why?
| | Abbreviations as Topic | 1 | 2008 | 2 | 0.020 |
Why?
| | Temperature | 1 | 2012 | 679 | 0.020 |
Why?
| | MEDLINE | 1 | 2008 | 21 | 0.020 |
Why?
| | Databases, Bibliographic | 1 | 2008 | 32 | 0.020 |
Why?
| | Lung | 1 | 2001 | 4060 | 0.020 |
Why?
| | Sarcoma, Experimental | 1 | 1987 | 7 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7635 | 0.020 |
Why?
| | Immunization, Passive | 1 | 1987 | 90 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5778 | 0.020 |
Why?
| | Macrophage Activation | 1 | 1987 | 201 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6828 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2804 | 0.010 |
Why?
| | Mesentery | 1 | 2005 | 48 | 0.010 |
Why?
| | Peritoneal Neoplasms | 1 | 2005 | 93 | 0.010 |
Why?
| | Fatal Outcome | 1 | 2005 | 303 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 1987 | 449 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 352 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5131 | 0.010 |
Why?
| | Codon | 1 | 2001 | 89 | 0.010 |
Why?
| | Hemochromatosis Protein | 1 | 2000 | 3 | 0.010 |
Why?
| | Carcinogens | 1 | 2001 | 125 | 0.010 |
Why?
| | Genes, MHC Class I | 1 | 2000 | 35 | 0.010 |
Why?
| | Free Radicals | 1 | 2000 | 110 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 173 | 0.010 |
Why?
| | Copper | 1 | 2000 | 104 | 0.010 |
Why?
| | Mutagenesis | 1 | 2000 | 179 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 240 | 0.010 |
Why?
| | Aldehydes | 1 | 2000 | 145 | 0.010 |
Why?
| | Rabbits | 1 | 2000 | 794 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 203 | 0.010 |
Why?
| | HLA Antigens | 1 | 2000 | 240 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 4193 | 0.010 |
Why?
| | Iron | 1 | 2000 | 313 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 10388 | 0.010 |
Why?
| | Cell Line | 1 | 2000 | 2847 | 0.010 |
Why?
| | United States | 1 | 2012 | 14841 | 0.010 |
Why?
| | Smoking | 1 | 2001 | 1627 | 0.010 |
Why?
| | Indium | 1 | 1987 | 9 | 0.000 |
Why?
| | Radioisotopes | 1 | 1987 | 31 | 0.000 |
Why?
| | Infant | 1 | 2001 | 9465 | 0.000 |
Why?
| | Child, Preschool | 1 | 2001 | 11074 | 0.000 |
Why?
| | Interleukin-2 | 1 | 1987 | 455 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1987 | 886 | 0.000 |
Why?
| | Cell Movement | 1 | 1987 | 967 | 0.000 |
Why?
| | Child | 1 | 2001 | 21935 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1987 | 5757 | 0.000 |
Why?
| | Mice | 1 | 1987 | 17787 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|